Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | EVP & Chief Financial Officer | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,926 |
Ending reported balance
After 2026-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-11 · Grant · Acquired 3,610 · Balance 25,926 F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Row 2 · 2026-02-11 · Grant · Acquired 4,718 · Balance 30,644 F2: Represents the vesting of performance stock units (includes 78 dividend equivalent shares) for the 2023-2025 performance period. Row 3 · 2026-02-11 · Tax withholding · Disposed 2,416 · Balance 28,228 F3: 2,416 of the 4,718 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Row 4 · 2026-02-12 · Tax withholding · Disposed 302 · Balance 27,926 F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $178.68 · Expires 2036-02-11 | Direct | 13,200 |
Reported balance
After 2026-02-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-11 · Grant · Acquired 13,200 · Balance 13,200 F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 1,086 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,086 |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Represents the vesting of performance stock units (includes 78 dividend equivalent shares) for the 2023-2025 performance period.
F3: 2,416 of the 4,718 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2026 Filed Feb 13, 2026 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 302 | $177.49 | $53,601.98 |
DisclosureSEC source: 0001140361-26-005510 · form4.xml · nonDerivative · entry 4 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,926 F4 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 13,200 | $0.00 Strike: $178.68 | $0.00 |
DisclosureSEC source: 0001140361-26-005510 · form4.xml · derivative · entry 6 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Stock · 13,200 shares Expires 2036-02-11 F5 · derivative.exercise_date: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,416 | $178.68 | $431,690.88 |
DisclosureSEC source: 0001140361-26-005510 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,228 F3 · shares: 2,416 of the 4,718 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 4,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005510 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,644 F2 · shares: Represents the vesting of performance stock units (includes 78 dividend equivalent shares) for the 2023-2025 performance period. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 3,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005510 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,926 F1 · shares: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 21:28 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 863 | $173.16 | $149,437.08 |
DisclosureSEC source: 0001140361-26-004613 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,316 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/8/2023). Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:11 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,781 | $163.14 | $453,692.34 |
DisclosureSEC source: 0001140361-25-004898 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,179 F3 · shares: 2,781 of the 5,432 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:11 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 5,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004898 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,960 F2 · shares: Represents the vesting of performance stock units (includes 89 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 22:15 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,781 | $163.14 | $453,692.34 |
DisclosureSEC source: 0001140361-25-013555 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,179 F3 · shares: 2,781 of the 5,432 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 22:15 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 5,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013555 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,960 F2 · shares: Represents the vesting of performance stock units (includes 89 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:11 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 7,700 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-004898 · form4.xml · derivative · entry 5 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,700 Underlying: Common Stock · 7,700 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:11 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004898 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,528 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 22:15 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 7,700 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-013555 · form4.xml · derivative · entry 5 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,700 Underlying: Common Stock · 7,700 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 22:15 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013555 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,528 F1 · shares: Ownership of restricted stock vests in Reporting Person ratably over a 3 year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:18 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 777 | $159.39 | $123,846.03 |
DisclosureSEC source: 0001140361-25-004100 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,168 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/10/2022). Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 22:58 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 832 | $145.33 | $120,914.56 |
DisclosureSEC source: 0001140361-24-007553 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,746 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 6,800 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · derivative · entry 4 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,800 Underlying: Common Stock · 6,800 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,868 | $143.43 | $411,357.24 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,578 F4 · shares: 2,868 of the 4,965 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 4,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,446 F3 · shares: Represents the vesting of performance stock units (includes 75 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,481 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 501 | $135.67 | $67,970.67 |
DisclosureSEC source: 0001140361-23-007251 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,242 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 5,500 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · derivative · entry 4 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,759 | $138.09 | $242,900.31 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,743 F4 · shares: 1,759 of the 3,372 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 3,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,502 F3 · shares: Represents the vesting of performance stock units (includes 50 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:34 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006112 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,130 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:43 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 664 | $137.73 | $91,452.72 |
DisclosureSEC source: 0001140361-22-005588 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,370 F1 · shares: 664 of the 1,300 Restricted Shares (date of grant 02/13/2019) that vested 02/14/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 5,000 | $0.00 Strike: $138.07 | $0.00 |
DisclosureSEC source: 0001140361-22-005086 · form4.xml · derivative · entry 4 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,100 Underlying: Common Stock · 5,000 shares Expires 2032-02-10 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,873 | $138.07 | $258,605.11 |
DisclosureSEC source: 0001140361-22-005086 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,034 F3 · shares: 1,873 of the 3,660 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 3,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005086 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,907 F2 · shares: Acquired upon the settlement of performance shares granted on February 13, 2019 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005086 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,247 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 18:44 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,074 | $139.51 | $289,343.74 |
DisclosureSEC source: 0001140361-22-004086 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,816 F1 · shares: 2,074 of the 4,000 Restricted Shares (date of grant 02/04/2019) that vested 02/04/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:51 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 5,300 | $0.00 Strike: $119.13 | $0.00 |
DisclosureSEC source: 0001140361-21-005117 · form4.xml · derivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,100 Underlying: Common Stock · 5,300 shares Expires 2031-02-13 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:51 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005117 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,730 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 21:29 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,996 | $113.59 | $226,725.64 |
DisclosureSEC source: 0001140361-21-003609 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,260 F1 · shares: 1,996 of the 4,000 Restricted Shares (date of grant 02/04/2019) that vested 02/04/2021 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 15:45 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 4,800 | $0.00 Strike: $111.94 | $0.00 |
DisclosureSEC source: 0001140361-20-003481 · form4.xml · derivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,800 Underlying: Common Stock · 4,800 shares Expires 2030-02-13 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 15:45 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003481 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,087 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 05, 2020 Filed Feb 5, 2020 18:28 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,394 | $111.98 | $156,100.12 |
DisclosureSEC source: 0001246360-20-000382 · form.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,098 F1 · acquired: 1,394 of the 4,000 shares that vested on February 4, 2020 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 18:09 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 6,000 | $0.00 Strike: $84.09 | $0.00 |
DisclosureSEC source: 0001140361-19-003354 · form4.xml · derivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,100 Underlying: Common Stock · 6,000 shares Expires 2029-02-13 F2 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 18:09 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003354 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,300 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.